Optimizing Postpartum Diabetes Screening: The Case for Immediate Inpatient Testing After Gestational Diabetes

MedXY Editorial Team•Mar 20, 2026•Clinical Updates

Inpatient administration of the oral glucose tolerance test (OGTT) prior to hospital discharge increases screening compliance by more than threefold compared to standard outpatient care (92.3% vs. 26.9%).
Patient satisfaction is significantly higher with the inpatient testing model, as measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ).
Early inpatient testing led to a higher detection rate of glycemic abnormalities, identifying prediabetes or type 2 diabetes in 50% of the intervention group.
The DIP trial provides high-level evidence supporting recent clinical guidelines that advocate for flexible postpartum screening options to address long-standing gaps in follow-up.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Inpatient administration of the oral glucose tolerance test (OGTT) prior to hospital discharge increases screening compliance by more than threefold compared to standard outpatient care (92.3% vs. 26.9%).
Patient satisfaction is significantly higher with the inpatient testing model, as measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ).
Early inpatient testing led to a higher detection rate of glycemic abnormalities, identifying prediabetes or type 2 diabetes in 50% of the intervention group.
The DIP trial provides high-level evidence supporting recent clinical guidelines that advocate for flexible postpartum screening options to address long-standing gaps in follow-up.